Next-generation sequencing for guiding matched targeted therapies in people with relapsed or metastatic cancer.
Kazmi F. et al, (2025), Cochrane Database Syst Rev, 3
The Impact of Body Mass Index (BMI) on Clinical Outcomes for Patients Receiving Systemic Anti-Cancer Therapies for Advanced Clear Cell Renal Carcinoma.
Greene J. et al, (2025), Cancer Control, 32
The Assisi think tank focus review on postoperative radiation for lobular breast cancer.
Kaidar-Person O. et al, (2024), Radiother Oncol, 201
Estimated Doses to the Heart, Lungs and Oesophagus and Risks From Typical UK Radiotherapy for Early Breast Cancer During 2015-2023.
Holt F. et al, (2024), Clin Oncol (R Coll Radiol), 36, e322 - e332
Locoregional recurrence in studies of primary systemic therapy in early invasive breast cancer
Chen L. et al, (2024), The Breast, 103791 - 103791
Exploring locoregional treatment reporting in neoadjuvant systemic breast cancer treatment studies: A systematic review.
Jiang M. et al, (2024), Eur J Surg Oncol, 50
Prolonged bone health benefits for breast cancer patients following adjuvant bisphosphonate therapy: the BoHFAB study.
Brown J. et al, (2024), J Bone Miner Res, 39, 8 - 16
Breast-Conserving Surgery with or without Irradiation in Early Breast Cancer (PRIME II)
Haris PA. and Dodwell D., (2024), 50 Landmark Papers: Every Breast Surgeon Should Know, 217 - 220
Effect of Radiotherapy after Breast-Conserving Surgery on 10-Year Recurrence and 15-Year Breast Cancer Death: Meta-Analysis of Individual Patient Data for 10,801 Women in 17 Randomised Trials
Haris PA. and Dodwell D., (2024), 50 Landmark Papers: Every Breast Surgeon Should Know, 221 - 224
Effect of Radiotherapy after Mastectomy and Axillary Surgery on 10-Year Recurrence and 20-Year Breast Cancer Mortality: Meta-Analysis of Individual Patient Data for 8135 Women in 22 Randomised Trials
Haris PA. and Dodwell D., (2024), 50 Landmark Papers: Every Breast Surgeon Should Know, 229 - 232